Plain-English translation of NCT06796569 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand whether a specific blood marker called the Systemic Immune Inflammatory Index can help doctors measure how active lupus is and predict kidney damage. They will measure this marker in lupus patients—some with kidney involvement and some without—and compare the results to healthy volunteers. This could help doctors better monitor lupus and catch kidney problems earlier.
Lupus is a serious autoimmune disease that can damage the kidneys, but doctors don't always have good tools to predict who will develop kidney problems. This study hopes to find a simple blood test that could help warn doctors when kidney damage is starting.
You likely qualify if…
You likely don't qualify if…
If you participate, you will have blood drawn so doctors can count your white blood cells, platelets, and other immune markers using a special formula. You will also have your lupus disease activity measured using a standard scoring system. The entire process is a one-time visit involving blood tests and a brief clinical evaluation. There are no medications to take or lifestyle changes required.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Egypt
Enrollment target
~90 participants
Started
December 2024
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
16 Years and older
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Shorouk Mohamed abdelmageed, master degree
Sohag University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.